BILVIAY Trademark
BILVIAY is a USPTO trademark filed by Albireo AB. Status: Cancelled.
Prosecution Summary
Trademark Summary
The trademark BILVIAY is a standard character mark covering pharmaceutical products for the treatment of liver and gastrointestinal diseases and disorders in International Class 005, with additional domestic classes 006, 018, 044, 046, 051, and 052. It is owned by Albireo AB, a Swedish aktiebolag located in Göteborg. The mark was registered but is now cancelled under Section 8 effective May 2, 2025, due to failure to file an acceptable declaration of use.
Recent Activity
Filed on February 5, 2018, the application proceeded through examination, including office actions and amendments, before publishing for opposition on July 31, 2018, and registering on the Principal Register on October 16, 2018. It was cancelled on May 2, 2025, for Section 8 n
Trademark Facts
| Mark | BILVIAY |
|---|---|
| Serial Number | 87783792 |
| Registration Number | 5584399 |
| Status | Cancelled |
| Filing Date | 2018-02-05 |
| Registration Date | 2018-10-16 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Albireo AB |
| Attorney of Record | Christina M. Licursi |
| Prosecution Events | 33 |
| Latest Event | C8.. on 2025-05-02 |
Goods & Services
Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders